Type of non Hodgkin's lymphoma-Other-Peripheral T-cell lymphoma Posts on Medivizor
Navigation Menu

Type of non Hodgkin’s lymphoma-Other-Peripheral T-cell lymphoma Posts on Medivizor

Which type of stem cell transplant is best for patients with T-cell lymphoma?

Which type of stem cell transplant is best for patients with T-cell lymphoma?

Posted by on Sep 26, 2021 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study looked at the use of two types of stem cell transplant (SCT) in the treatment of T-cell lymphoma.  It found that both haploidentical and umbilical cord blood SCT were good options for these patients.  Some background T-cell lymphoma is a cancer affecting a certain type of blood cell called T-cells. T-cells are...

Read More

Evaluating the safety and effectiveness of geptanolimab unresponsive peripheral T cell lymphoma

Evaluating the safety and effectiveness of geptanolimab unresponsive peripheral T cell lymphoma

Posted by on Jan 31, 2021 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study assessed the effectiveness and safety of geptanolimab (GB226) in relapsed/refractory (r/r) peripheral T cell lymphoma (PTCL). The authors concluded that geptanolimab showed promising activity and manageable safety in these patients. Some background Peripheral T cell lymphoma (PTCL) is a rare subtype of non-Hodgkin...

Read More

Comparing the GDP and ICE regimens as salvage treatment for relapsed/refractory aggressive lymphoma

Comparing the GDP and ICE regimens as salvage treatment for relapsed/refractory aggressive lymphoma

Posted by on Jan 17, 2021 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study investigated the effectiveness and safety of GDP (gemcitabine, dexamethasone, and cisplatin) and ICE (ifosfamide, carboplatin, and etoposide) regimens as salvage therapy in patients with relapsed/refractory aggressive lymphoma. The data showed that both the GDP and ICE regimens are suitable options for relapsed/refractory...

Read More

How effective is a modified anti-nausea and vomiting treatment for patients with non-Hodgkin lymphoma undergoing chemotherapy?

How effective is a modified anti-nausea and vomiting treatment for patients with non-Hodgkin lymphoma undergoing chemotherapy?

Posted by on May 17, 2020 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study examined the effectiveness of a modified anti-nausea and vomiting treatment for patients with aggressive non-Hodgkin lymphoma (NHL) receiving high-dose (HD) chemotherapy. The results showed that netupitant/palonosetron (NEPA; Akynzeo) alone was very effective and safe for these patients. Some background Chemotherapy...

Read More

How effective and safe is high-dose chemotherapy and stem cell transplant for children with lymphoma?

Posted by on Apr 14, 2020 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study examined the effectiveness and safety of high-dose chemotherapy and stem cell transplants for children with lymphoma. The study showed that the combination treatment was very effective but that the dose may need to be adjusted for some patients. Some background Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL) have very...

Read More

Comparing chemotherapy dosing approaches for patients with non-Hodgkin lymphoma before a stem cell transplant

Posted by on Nov 28, 2019 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study evaluated two different dosing approaches for busulfan (Busilvex) chemotherapy for patients with non-Hodgkin lymphoma (NHL) before an autologous stem cell transplant (SCT). The authors found that personalizing treatment dose for these patients was more effective than conventional weight-based dosing. Some background...

Read More